Product Images Imovax Rabies

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Imovax Rabies NDC 49281-252 by Sanofi Pasteur Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure - imovax 01

Figure - imovax 01

The text appears to describe components of a syringe, including a syringe cap, plunger, syringe tip cap, rod, and barrel. These components are crucial for the function of a syringe in administering medications or fluids.*

Figure - imovax 02

Figure - imovax 02

Figure - imovax 03

Figure - imovax 03

PRINCIPAL DISPLAY PANEL - 1 mL Vial Label - imovax 04

PRINCIPAL DISPLAY PANEL - 1 mL Vial Label - imovax 04

This is a label of a medical product produced and distributed by Sanofi Pasteur. It contains a unique identification number and contact information for the manufacturer and distributor.*

PRINCIPAL DISPLAY PANEL - 1 mL Syringe Label - imovax 05

PRINCIPAL DISPLAY PANEL - 1 mL Syringe Label - imovax 05

This text is a description of a product called "Sterile Water", which is a diluent used for reconstitution of a substance known as USP R. The product is manufactured by Sanofi Pasteur and does not contain any preservatives. The product has a National Drug Code (NDC) of 49281-263-58 and is identified by the number 768915.*

PRINCIPAL DISPLAY PANEL - Kit Carton - imovax 06

PRINCIPAL DISPLAY PANEL - Kit Carton - imovax 06

This appears to be information about a rabies vaccine called IMOVAX® RABIES. It is a single-dose, lyophilized vaccine that is reconstituted with sterile water and administered through intramuscular injection. It is not for intradermal use. The vaccine is manufactured by Sanofi Pasteur SA in Lyon, France, and distributed by Sanofi Pasteur Inc. in Swiftwater, PA, USA. The vaccine is stored at 2°C to 8°C (35°F to 46°F) and has a potency of equal to or greater than 2.5 IU/mL of rabies antigen.*

PRINCIPAL DISPLAY PANEL - 1 mL Vial Label - imovax 07

PRINCIPAL DISPLAY PANEL - 1 mL Vial Label - imovax 07

IMOVAX RABIES is a vaccine manufactured by Sanofi Pasteur SA in Lyon, France. The vaccine contains 5% Rabies and is intended for intramuscular injections only. US Government Lic #1724. The vaccine is distributed by Sanofi Pasteur Inc. in Swiftwater, PA, and their contact number is 1-800-VACCINE (1-800-822-2463).*

PRINCIPAL DISPLAY PANEL - 1 mL Syringe Label - imovax 08

PRINCIPAL DISPLAY PANEL - 1 mL Syringe Label - imovax 08

This is a description of a product that has the National Drug Code (NDC) number 49281-249-01. It is a sterile water diluent used for reconstitution of something, possibly a medication or vaccine. The product is manufactured by Sanofi Pasteur and it does not contain any preservatives. The text is accompanied by a barcode labeled "967980".*

PRINCIPAL DISPLAY PANEL - Kit Carton - imovax 09

PRINCIPAL DISPLAY PANEL - Kit Carton - imovax 09

IMOVAX RABIES is a rabies vaccine for human use that is manufactured by Sanofi Pasteur SA in Lyon, France. The vaccine comes in a dose of 1 ml and is distributed by Sanofi Pasteur Inc. The potency of the vaccine is equal to or greater than 2.5 IUmL of rabies antigen, it contains no preservative, and less than 150 ig neomycin sulfate per dose. The vaccine is not for intradermal use, for intramuscular injection only, and is grown in human diploid cell cultures. Storage is recommended at 2°C to 8°C (35°F to 46°F). The package comes with enclosed instructions. CPT Code: 90675.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.